LBCL

SOUTH SAN FRANCISCO, Calif., June 12, 2026 Lyell Immunopharma, Inc. announced updated safety and translational data for rondecabtagene autoleucel...

South San Francisco, California | April 13, 2026 Allogene Therapeutics has announced encouraging interim results from its pivotal Phase...

South San Francisco, California | April 10, 2026 Allogene Therapeutics has announced that it will present the interim futility...